Gold Nanoparticles: An Emerging Novel Technology for Targeted Delivery System for Site-Specific Diseases

IF 0.3 Q4 PHARMACOLOGY & PHARMACY
Prevesh Kumar, Phool Chandra, Navneet Verma, Diksha, Aditya Sharma, M. Mani, Zaira Hussain
{"title":"Gold Nanoparticles: An Emerging Novel Technology for Targeted Delivery System for Site-Specific Diseases","authors":"Prevesh Kumar, Phool Chandra, Navneet Verma, Diksha, Aditya Sharma, M. Mani, Zaira Hussain","doi":"10.2174/0115748855314069240709091743","DOIUrl":null,"url":null,"abstract":"\n\nGold Nanoparticles (GNPs) have emerged as a novel technology in the field of targeted\ndelivery systems, offering promising solutions for site-specific disease treatment. These nanoparticles\npossess unique physicochemical properties, such as controlled size, shape, and surface chemistry,\nwhich enable precise manipulation for enhanced therapeutic efficacy. The biocompatibility and ease\nof functionalization of GNPs facilitate the conjugation with various biomolecules, including drugs,\npeptides, and nucleic acids, thereby improving their targeted delivery capabilities. Recent advancements\nin nanotechnology have leveraged GNPs for the treatment of a range of diseases, particularly\nin oncology, cardiology, and neurology. In cancer therapy, GNPs can be engineered to target tumor\ncells selectively, minimizing damage to healthy tissues and reducing side effects. This is achieved\nthrough the conjugation of GNPs with tumor-specific ligands, antibodies, or aptamers, which direct\nthe nanoparticles to malignant cells, allowing for localized drug release and improved therapeutic\noutcomes. Moreover, GNPs exhibit remarkable potential in diagnostic imaging and photothermal\ntherapy. Their unique optical properties, such as surface plasmon resonance, enable their use as contrast\nagents in imaging techniques, providing high-resolution and real-time monitoring of disease\nprogression. In photothermal therapy, GNPs convert light energy into heat, effectively destroying\ntargeted cells with minimal invasiveness. The development of GNP-based delivery systems also addresses\nsignificant challenges in drug resistance and bioavailability. By overcoming biological barriers\nand enhancing cellular uptake, GNPs improve the pharmacokinetics and pharmacodynamics of\ntherapeutic agents. However, despite these advancements, the clinical translation of GNPs faces challenges\nsuch as potential toxicity, long-term stability, and regulatory hurdles. In conclusion, gold nanoparticles\nrepresent a cutting-edge approach in targeted delivery systems, offering significant potential\nfor site-specific disease treatment. Continued research and innovation are essential to overcome\nexisting challenges and fully realize the clinical applications of GNPs, ultimately revolutionizing\nprecision medicine.\nGold nanoparticles exhibit unique physicochemical and optical properties. The gold nanoparticles\nhave advanced techniques to cure different chronic diseases. Today, gold nanoparticles are aided by\nphotodynamic therapy and radiation therapy as drug carriers. Due to this, researchers now focus on\nmedical sciences to treat various diseases and therapeutic applications. This review provides all the\naspects of gold-based nanoparticles, methods, and their pharmacological benefits in different fields\nof medical sciences. We also discuss various preparation methods and their advantages in pharmaceutical\nformulations.\n","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748855314069240709091743","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Gold Nanoparticles (GNPs) have emerged as a novel technology in the field of targeted delivery systems, offering promising solutions for site-specific disease treatment. These nanoparticles possess unique physicochemical properties, such as controlled size, shape, and surface chemistry, which enable precise manipulation for enhanced therapeutic efficacy. The biocompatibility and ease of functionalization of GNPs facilitate the conjugation with various biomolecules, including drugs, peptides, and nucleic acids, thereby improving their targeted delivery capabilities. Recent advancements in nanotechnology have leveraged GNPs for the treatment of a range of diseases, particularly in oncology, cardiology, and neurology. In cancer therapy, GNPs can be engineered to target tumor cells selectively, minimizing damage to healthy tissues and reducing side effects. This is achieved through the conjugation of GNPs with tumor-specific ligands, antibodies, or aptamers, which direct the nanoparticles to malignant cells, allowing for localized drug release and improved therapeutic outcomes. Moreover, GNPs exhibit remarkable potential in diagnostic imaging and photothermal therapy. Their unique optical properties, such as surface plasmon resonance, enable their use as contrast agents in imaging techniques, providing high-resolution and real-time monitoring of disease progression. In photothermal therapy, GNPs convert light energy into heat, effectively destroying targeted cells with minimal invasiveness. The development of GNP-based delivery systems also addresses significant challenges in drug resistance and bioavailability. By overcoming biological barriers and enhancing cellular uptake, GNPs improve the pharmacokinetics and pharmacodynamics of therapeutic agents. However, despite these advancements, the clinical translation of GNPs faces challenges such as potential toxicity, long-term stability, and regulatory hurdles. In conclusion, gold nanoparticles represent a cutting-edge approach in targeted delivery systems, offering significant potential for site-specific disease treatment. Continued research and innovation are essential to overcome existing challenges and fully realize the clinical applications of GNPs, ultimately revolutionizing precision medicine. Gold nanoparticles exhibit unique physicochemical and optical properties. The gold nanoparticles have advanced techniques to cure different chronic diseases. Today, gold nanoparticles are aided by photodynamic therapy and radiation therapy as drug carriers. Due to this, researchers now focus on medical sciences to treat various diseases and therapeutic applications. This review provides all the aspects of gold-based nanoparticles, methods, and their pharmacological benefits in different fields of medical sciences. We also discuss various preparation methods and their advantages in pharmaceutical formulations.
金纳米粒子:用于治疗特定部位疾病的靶向传输系统的新兴技术
金纳米粒子(GNPs)已成为靶向给药系统领域的一项新技术,为特定部位的疾病治疗提供了前景广阔的解决方案。这些纳米粒子具有独特的物理化学特性,如尺寸、形状和表面化学性质可控,从而可以精确操作以提高疗效。GNPs 的生物相容性和易于功能化的特点有利于与各种生物大分子(包括药物、肽和核酸)共轭,从而提高其靶向递送能力。纳米技术的最新进展利用 GNPs 治疗了一系列疾病,尤其是肿瘤、心脏病和神经病学方面的疾病。在癌症治疗中,GNP 可以有选择性地靶向肿瘤细胞,最大限度地减少对健康组织的损害并降低副作用。这是通过将 GNPs 与肿瘤特异性配体、抗体或适配体结合来实现的,这些配体、抗体或适配体可将纳米粒子导向恶性细胞,从而实现局部药物释放并改善治疗效果。此外,GNPs 在诊断成像和光热疗法方面也具有显著的潜力。GNPs 具有独特的光学特性,如表面等离子体共振,可用作成像技术中的造影剂,提供高分辨率和实时的疾病进展监测。在光热疗法中,GNPs 可将光能转化为热能,以最小的创口有效摧毁靶细胞。基于 GNP 的给药系统的开发还解决了耐药性和生物利用度方面的重大挑战。通过克服生物障碍和提高细胞吸收,GNP 改善了治疗药物的药代动力学和药效学。然而,尽管取得了这些进展,GNPs 的临床应用仍面临着潜在毒性、长期稳定性和监管障碍等挑战。总之,金纳米粒子代表了靶向给药系统的前沿方法,为特定部位的疾病治疗提供了巨大潜力。要克服现有的挑战并充分实现金纳米粒子的临床应用,最终彻底改变精准医学,持续的研究和创新至关重要。金纳米粒子具有独特的物理化学和光学特性,是治疗各种慢性疾病的先进技术。如今,金纳米粒子已成为光动力疗法和放射疗法的辅助药物载体。因此,研究人员现在把重点放在医学科学上,以治疗各种疾病和治疗应用。本综述介绍了金基纳米粒子的各个方面、方法及其在不同医学领域的药理作用。我们还讨论了各种制备方法及其在药物制剂中的优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Drug Therapy
Current Drug Therapy PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
50
期刊介绍: Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信